Research Calls
- Upgrades:
- Advanced Micro (AMD) upgraded to Buy from Neutral at UBS; tgt raised to $95
- Advanced Micro (AMD) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $100
- Allete (ALE) upgraded to Buy from Neutral at BofA Securities; tgt raised to $66
- Americold Realty Trust (COLD) upgraded to Buy from Neutral at BofA Securities; tgt raised to $33.50
- ASML (ASML) upgraded to Positive from Neutral at Susquehanna; tgt raised to $850
- Atlas Copco AB (ATLKY) upgraded to Buy from Neutral at Citigroup
- Beam Global (BEEM) upgraded to Buy from Neutral at H.C. Wainwright; tgt $30
- Blend Labs (BLND) upgraded to Mkt Perform from Underperform at Keefe Bruyette; tgt $2.25
- Dominion Energy (D) upgraded to Neutral from Sell at Goldman; tgt lowered to $69
- MacroGenics (MGNX) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $16
- Medical Properties Trust (MPW) upgraded to Buy from Neutral at BofA Securities; tgt raised to $16
- Occidental Petro (OXY) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $74
- Oak Street Health (OSH) upgraded to Overweight from Equal-Weight at Morgan Stanley
- Ritchie Bros. (RBA) upgraded to Buy from Neutral at Northcoast; tgt $65
- Veris Residential (VRE) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $1
- Downgrades:
- Alexander & Baldwin (ALEX) downgraded to Neutral from Overweight at Piper Sandler; tgt $20
- Algonquin Power & Utilities (AQN) downgraded to Hold from Buy at Desjardins
- Algonquin Power & Utilities (AQN) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $11
- Algonquin Power & Utilities (AQN) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $12
- Archaea Energy (LFG) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $26
- Ares Management (ARES) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt $93
- Bank of America (BAC) downgraded to Neutral from Buy at Citigroup; tgt $40
- Barings BDC (BBDC) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $10
- CGI Group (GIB) downgraded to Hold from Buy at Societe Generale
- Chart Industries (GTLS) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $148
- CytomX Therapeutics (CTMX) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $2.60
- Dr. Reddy's (RDY) downgraded to Underperform from Neutral at Credit Suisse
- EQRx (EQRX) downgraded to Underweight from Neutral at JP Morgan
- Essex Property (ESS) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $233
- Global Payments (GPN) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $118
- Grainger (GWW) downgraded to Peer Perform from Outperform at Wolfe Research
- Hasbro (HAS) downgraded to Underperform from Buy at BofA Securities; tgt lowered to $42
- Lyell Immunopharma (LYEL) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $7
- NETSTREIT (NTST) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $21
- Neurocrine Biosciences (NBIX) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $130
- NIO (NIO) downgraded to Hold from Buy at China Renaissance; tgt lowered to $12.30
- Orsted A/S (DNNGY) downgraded to Neutral from Buy at Goldman
- Omega Health (OHI) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $33
- Oscar Health (OSCR) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt $5
- Sabra Health Care REIT (SBRA) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $13
- Spirit Realty Capital (SRC) downgraded to Neutral from Buy at BofA Securities; tgt raised to $43
- Sierra Bancorp (BSRR) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $24
- Teleperformance (TLPFY) downgraded to Buy from Conviction Buy at Goldman
- Teva Pharma (TEVA) downgraded to Underweight from Neutral at JP Morgan; tgt lowered to $10
- Others:
- Bunzl PLC (BZLFY) assumed with a Neutral at Credit Suisse
- Cboe Global Markets (CBOE) initiated with a Neutral at Redburn
- Intertek Group (IKTSY) assumed with an Outperform at Credit Suisse
- Janux Therapeutics (JANX) initiated with an Outperform at William Blair
- NASDAQ (NDAQ) initiated with a Neutral at Redburn
- Prime Medicine (PRME) initiated with a Buy at Jefferies; tgt $25
- Prime Medicine (PRME) initiated with a Neutral at Goldman; tgt $22
- Prime Medicine (PRME) initiated with an Equal-Weight at Morgan Stanley; tgt $23
- Prime Medicine (PRME) initiated with an Overweight at JP Morgan; tgt $27
- Sachem Capital (SACH) initiated with a Mkt Perform at JMP Securities
- Swiss Life (SZLMY) assumed with a Neutral at Credit Suisse